Funding for Bioscience research from the European Union

1
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Funding for Bioscience research from the European
Union The Framework Programme Claire
Horton National Contact Point for Life Sciences
OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
2
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK

• In this presentation
• Aim to provide a general overview of some
  aspects of the current Framework - FP6
• Including General rules of participation
  funding fundamentals
• What can be funded?
• When will I get the money?
• Bioscience funding where in FP6?
• When can I apply?
• Is it for me? some questions to consider
• Why apply?
• Help and assistance available

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
3
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Introduction to the Framework Programme

• Framework Programme is the current EU scheme of
  support for collaborative RD for organisations
  of all sizes
• Framework Programme initiated in 1984
• Runs in four-yearly cycles
• Current Framework Programme (FP6) covers the
  period 2002-2006
• Funds for FP6 19 billion (approx 13
  billion).
• Aim
• Strengthen science and technology in the EU and
  encourage international competitiveness

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
4
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
European Research Priorities for FP6
Budget B TP1 Life Sciences,
genomics biotechnology for health 2.2 TP2 Tech
nologies for the Information Society 3.6 TP3
Nanotechnologies and nanosciences
1.3 TP4Aeronautics space 1.1 TP5 Food
Quality and Safety 0.7 TP6 Sustainable
development and global change 2.1 TP7 Citizens
and governance 0.2 Total 11.2
B Become the worlds most competitive and
dynamic knowledge-based economy in the world
EC March 2000
OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
5
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Funding Fundamentals

• Open to any legal entity in Europe
• Trans-European collaboration between a minimum of
  three partners from three separate EU countries
• In general the EC gives you 50 of the budget
• No commercial gain during the duration of the
  project
• There must be some risk, high yield and high
  impact in Europe.
• In response to specific calls for proposals
• Research to be funded is outlined in
  workprogrammes
• Instruments - The different methods that must be
  used to access money
• Evaluation by independent experts
• Subject to contract

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
6
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Accessing the funding

• FP6 instruments
• Integrated Projects (IP)
• Networks of Excellence (NoE)
• Specific Targeted Research Projects (STREPs)
• Co-ordination Actions (CAs)
• Specific Support Actions (SSAs)
• Also SME specific activities
• - Co-operative and Collective research

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
7
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Instruments
OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
8
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
What can be funded?

• Research 50 support
• eg., payroll costs of staff, consumables,
  equipment.
• Management 100 support
• eg., management of project, travel to meetings,
  annual audit certificates
• Demonstration 35 support
• eg., testing of prototypes
• Innovation 50 support
• eg., IP protection, dissemination activities,
• Training 100 support
• eg., staff exchanges and PhD programmes
• NB Grant to budget will vary according to cost
  model of each participant and instrument.
• Use the Guide for Proposers for each instrument
  and Financial Guidelines for FP6

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
9
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
When will I get the money?
Start!
WIN
OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
10
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Bioscience research funding where in FP6?

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
11
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Funding for Biosciences

• TP2 Information Society Technology Anywhere,
  anytime access to IST services for all
• Integrated biomedical information for better
  health
• TP3 Nanotechnology Technologies to transform
  the manufacturing industry
• Nanotechnology-based targeted drug delivery.
• Biomaterial technologies for implants
• TP5 Food Quality and Safety Influence of food
  intake and environmental factors on human health.
• Influence of dietary history on coeliac disease.
• Diet and Cardiovascular diseases.
• Investigation of TSE and development of detection
  and control strategies
• Frontier research Critical research of
  tomorrow' Visionary and ground breaking research
  that does not fall within the PTAs
• Co-operative research and Collective research
  SME specific activity in any area of science and
  technology

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
12
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Thematic Area One Life Sciences, Genomics and
Biotechnology for Health

• To date - Three calls for proposals.
  Future One more call, May 2005.
• Examples of research areas to date
• Gene expression and proteomics
• Structural genomics
• Bioinformatics
• New diagnostics
• In vitro tests to replace animal experimentation
• New therapeutic tools
• Combating CVD, diabetes, cancer and rare diseases
• Combating resistance to antibiotics
• Confronting diseases linked to poverty

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
13
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Life Sciences, Genomics and Biotechnology for
Health Final Call

• Total Indicative budget 539M
• Main call 368M - There will be a higher
  proportion of STREPS
• SME-call 171M - Instrument - SME - STREP
• Aim reinforcement of the scientific and
  technological knowledge of SMEs
• For research intensive SMEs with the possible
  participation of Universities, research
  centres, other industries.
• Results should be of interest and benefit of
  SMEs.
• Budget going to SME participants must be
  substantial (30-50 per consortium).
• Calls due to open May 2005

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
14
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
When can I apply?
Current and future calls of possible interest to
bioscientists
Contact the relevant NCP for details of the area
that you are interested in View
http//fp6uk.ost.gov.uk for contact details
OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
15
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Is FP6 for me?

• To make the best use of EC funding you need a
  reasonable long term company strategy. Consider
  the following
• Is there coherence between your research goals
  and what the EU wants to fund? (read the
  workprogramme)
• Do you see benefits in collaborating with other
  EU organisations?
• Can you commit considerable time and resource
  into preparing and participating in a project?
• Could you work in a consortium where there is a
  high level of responsibility?
• Are you prepared to enter a competition for
  funding?
• Can you commit to a 2-5 year project?
• Will you (your organisation) be able to finance
  the other 50 of your portion of the project
  work?
• Its not instant funding!

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
16
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Some Life Sciences figures

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
17
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Examples
Two UK Co-ordinated from first call to Life
Sciences Funded from Jan 2004 Proteases and
cancer biology 4-year IP University of East
Anglia Partners 32 in 13 countries, including 5
SMEs EC contribution 10.4 M New microbicides
for the prevention of HIV infection 5-year IP
European Microbicides Project (EMPRO) Kings
College, London Partners 25 in 9 countries,
including 4 SMEs and 1 large pharma EC
contribution 11.7 M www.empro.org.uk
OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
18
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Why apply?

• Consider the benefits in terms of
• Cost reduction for research you may wish to
  carry-out
• Development of new knowledge, products,
  processes, technologies
• Sharing expertise Access to skills, technology
  and the resources of project partners
• Scientific collaboration and training
  opportunities.
• Access to new contacts and networks build upon
  the new, strong, research linkages formed.
• Elevated research profile and publications

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
19
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Next steps

• Decide whether this type of funding is right for
  you
• Consider your company strategy
• Identify the appropriate Workprogramme
• Identify call date
• Training? consider attending FP6 workshops and
  seminars
• Search for Potential Partners/consortium to join
• Agree a consortium
• Prepare and submit a proposal
• Use CORDIS the EUs information site
• workprogrammes, proposal forms and guides for
  proposers and other important documents, news and
  events
• Contact your NCP

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
20
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Help and Assistance

European Commission Community RD Information
Service (CORDIS) www.cordis.lu Helpdesks SME
Helpdesk research-sme_at_cec.eu.int IPR
Helpdeskwww.ipr-helpdesk.org UK Network of
National Contact Points (NCP) http//fp6uk.ost.gov
.uk TP1 NCP - Helpline for enquires - One to
one meetings - Assistance with proposal
preparation - Pre-screening of proposals -
Organisation of events and workshops -
Information bulletins - Case studies - Free
and confidential assistance

OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL
21
FP6UK LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY
FP6UK
Contact details


Claire Horton National Contact Point for Life
Sciences TP1 Biotech helpline 0870 191 0111 E
mail biotech_at_fp6uk.co.uk Free and confidential
service brought to you by funding from the DTI
OFFICE OF SCIENCE AND TECHNOLOGY
MEDICAL RESEARCH COUNCIL